News

How local regulations helped create certainty and safety principles that enabled biotech's massive growth
A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...
Amid an onshoring push, Raleigh is poised to be pharma’s next manufacturing hub
Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma ...
Pharmabiz1d
Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission
Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission: Tokyo Wednesday, April 16, 2025, 11:00 Hrs [I ...
Leqembi®âˆ‡ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and ...
Biogen Inc.: Leqembi? (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...
‘I think it is actively happening’: Is Boston’s biotech industry doomed?
With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...
Nurse wins prestigious award, for helping kids with chronic pain
A nurse practitioner whose research at Toronto's Hospital for Sick Children is dedicated to helping children and teens manage ...
These Eight Scientists Have Advanced Our Understanding of Human Health and Disease
Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...